Related Experiment Video
Updated: Aug 9, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
[Public access defibrillators--beneficial?]
Sverre Rørtveit1, Eivind Meland
1Kommunelegekontoret, 5399 Bekkjarvik. sverre.rortveit@austevoll.kommune.no
Insights
Public access defibrillators may not improve survival rates for sudden cardiac death in Norway. Despite recommendations, evidence suggests variable outcomes, indicating a need for further research into effective public health strategies for cardiac arrest.
Area of Science:
- Cardiology
- Public Health
- Emergency Medicine
Context:
- Sudden cardiac death (SCD) affects over 3000 individuals annually in Norway, primarily due to ventricular fibrillation.
- International guidelines recommend public-access defibrillators (PAD) and training for non-medical personnel.
Purpose:
- To evaluate the effectiveness of the public-access defibrillation strategy in Norway.
- To analyze survival rates from cardiac arrest based on existing studies.
Summary:
- A systematic review of studies on PAD, city-wide projects, and cardiac arrest epidemiology was conducted.
- PAD strategies showed the highest survival frequencies in some studies, but results varied significantly by location and population.
- Ventricular fibrillation as a cause of cardiac arrest is decreasing over time.
Impact:
- The study concludes that implementing a public-access defibrillator strategy is unlikely to significantly improve survival rates from cardiac arrest in Norway.
- Findings suggest that current predictor models do not fully explain the diverse survival outcomes observed across different populations.
Background:
In Norway, every year more than 3000 persons suffer sudden cardiac death caused by ventricular fibrillation. The present recommendations of international expert committees are that the use of public-access defibrillators should be encouraged, including training of non-medical personnel.
Material And Method:
In order to evaluate the validity of such recommendations, we performed searches in Medline on relevant keywords and evaluated articles thus identified and their references. We selected studies on countries, cities, public access defibrillator projects, and on epidemiology of cardiac arrest and ventricular fibrillation.
Results:
Studies of the public-access defibrillation strategy reported the highest frequencies of survival. Studies from cities gave highly variable results; those for entire countries poor results. Different populations have different results of survival, and commonly used predictor models do not comprehensibly explain these findings. Over time there is a falling frequency of ventricular fibrillation as the cause of cardiac arrest.
Interpretation:
Application of the strategy of public-access defibrillators will not result in significantly improved survival from cardiac arrest in Norway.
Related Concept Videos
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Cardiopulmonary Resuscitation I: Adult
Cardiopulmonary Resuscitation III: AED Use
Cardiopulmonary Resuscitation IV: Pharmacological Management
Heart Failure VI: Adjunct Therapies
Cardiomyopathy V: Interprofessional Care

